Related Articles

• The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)
• Serum IGFBP‑3 is a more effective predictor than IGF‑1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection
• Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study
• Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma
• Prophylactic effect of peptide vaccination against hepatocellular carcinoma associated with hepatitis C virus